These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 13719322)

  • 1. An electrophysiologic study of the neuromuscular junction in myasthenia gravis.
    DAHLBACK O; ELMQVIST D; JOHNS TR; RADNER S; THESLEFF S
    J Physiol; 1961 Apr; 156(2):336-43. PubMed ID: 13719322
    [No Abstract]   [Full Text] [Related]  

  • 2. Motor end plate changes in myasthenia gravis.
    CHURCHILL-DAVIDSON HC
    Am J Phys Med; 1959 Aug; 38():159-62. PubMed ID: 13810230
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies in neuromuscular function. II. Effects of nerve stimulation in normal subjects and in patients with myasthenia gravis.
    GROB D; HARVEY AM; JOHNS RJ
    Bull Johns Hopkins Hosp; 1956 Sep; 99(3):125-35. PubMed ID: 13364528
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuromuscular transmission in myasthenia gravis.
    CHURCHILL-DAVIDSON HC; RICHARDSON AT
    J Physiol; 1953 Nov; 122(2):252-63. PubMed ID: 13118536
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuromuscular transmission with a note on myasthenia gravis.
    MEAD JC
    McGill Med J; 1957 Apr; 26(2):88-95. PubMed ID: 13429923
    [No Abstract]   [Full Text] [Related]  

  • 6. Observations on the nature of the neuromuscular block in myasthenia gravis.
    HARVEY AM; GROB D; JOHNS RJ
    Trans Assoc Am Physicians; 1954; 67():94-6. PubMed ID: 13216816
    [No Abstract]   [Full Text] [Related]  

  • 7. Myasthenia gravis. III. Lack of inhibitory action of fractionated thymus extracts.
    ZACKS SI
    Proc Soc Exp Biol Med; 1958 Dec; 99(3):574-5. PubMed ID: 13614427
    [No Abstract]   [Full Text] [Related]  

  • 8. Ultra-structure of the myoneural junction in myasthenia gravis.
    BICKERSTAFF ER; EVANS JV; WOOLF AL
    Nature; 1959 Nov; 184(Suppl 19)():1500. PubMed ID: 13800492
    [No Abstract]   [Full Text] [Related]  

  • 9. Observations on the nature of the neuromuscular block in myasthenia gravis.
    GROB D; JOHNS RJ; HARVEY AM
    Trans Assoc Am Physicians; 1955; 68():50-3. PubMed ID: 13299310
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormalities in the fine structure of the neuromuscular junction in patients with myasthenia gravis.
    ZACKS SI; BAUER WC; BLUMBERG JM
    Nature; 1961 Apr; 190():280-1. PubMed ID: 13787615
    [No Abstract]   [Full Text] [Related]  

  • 11. Search for a neuromuscular blocking agent in the blood of patients with myasthenia gravis.
    NASTUK WL; STRAUSS AJ; OSSERMAN KE
    Am J Med; 1959 Mar; 26(3):394-409. PubMed ID: 13626994
    [No Abstract]   [Full Text] [Related]  

  • 12. Abnormalities in neuromuscular transmission, with special reference to myasthenia gravis.
    GROB D; HARVEY AM
    Am J Med; 1953 Nov; 15(5):695-709. PubMed ID: 13104438
    [No Abstract]   [Full Text] [Related]  

  • 13. Myasthenia Gravis and Related Diseases: Disorders of the Neuromuscular Junction. Proceedings of a conference. Santa Monica, California, USA. May 7-10, 1997.
    Ann N Y Acad Sci; 1998 May; 841():xvii-xviii, 1-838. PubMed ID: 9668216
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuromuscular transmission in myasthenia gravis.
    CHURCHILL-DAVIDSON HC; RICHARDSON AT
    Am J Med; 1955 Nov; 19(5):691-2. PubMed ID: 13268465
    [No Abstract]   [Full Text] [Related]  

  • 15. The fine structure of the myasthenic neuromuscular junction.
    ZACKS SI; BAUER WC; BLUMBERG JM
    J Neuropathol Exp Neurol; 1962 Jul; 21():335-47. PubMed ID: 14009526
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neuromuscular transmission in myasthenia gravis].
    Takamori M; Tajima H; Sugimoto S; Tsujihata M
    Naika; 1968 Apr; 21(4):761-7. PubMed ID: 4302046
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on myasthenia gravis.
    Thanvi BR; Lo TC
    Postgrad Med J; 2004 Dec; 80(950):690-700. PubMed ID: 15579606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies in neuromuscular function. VI. Effects of anticholinesterase compounds, d-tubocurarine, and decamethonium in patients with myasthenia gravis.
    GROB D; HARVEY AM; JOHNS RJ
    Bull Johns Hopkins Hosp; 1956 Oct; 99(4):219-38. PubMed ID: 13364533
    [No Abstract]   [Full Text] [Related]  

  • 19. THE CHEMICAL THEORY OF NEUROMUSCULAR TRANSMISSION AND SOME APPLICATIONS TO MYASTHENIA GRAVIS.
    THESLEFF S
    Rev Neuropsiquiatr; 1964 Sep; 27():209-23. PubMed ID: 14333863
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathogenic investigations on myasthenia and myotonia with special reference to therapy. II. Effect of blood serum isolated in myotonia on nerve-muscle preparation in frog].
    KURES H; MALEK P
    Cas Lek Cesk; 1952 Jun; 91(24-25):709-11. PubMed ID: 14390261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.